One Innovation Labs has rebranded and unveiled a dual-stage vitamin C system ahead of Vitafoods Europe 2025, reflecting its shift from behind-the-scenes R&D to a visible, science-driven partner in cognitive, sleep, skin, immunity, and wellness solutions.
Miami Lakes — One Innovation Labs has announced a company-wide rebrand and the launch of a new dual-stage vitamin C delivery system, coinciding with the company’s upcoming participation in Vitafoods Europe 2025, one of the global nutraceutical industry’s leading trade exhibitions.
The rebrand marks a strategic shift for the organization, which has historically operated as a research and development partner behind the scenes of the global supplement industry. The updated brand identity reflects an evolution into a more visible, science-led innovation partner working across multiple categories, including cognitive performance, sleep, skin health, immunity, and active wellness.
As part of this transition, One Innovation Labs is introducing Liposomal PureWay-C® + DUOCAP®, a two-stage vitamin C delivery system incorporating the company’s proprietary LiposoMax
technology. The system combines liposomal encapsulation for early absorption with delayed-release delivery designed to sustain nutrient availability. The formulation uses Lonza’s DUOCAP® capsule-in-capsule format and is intended to address known formulation challenges related to vitamin C delivery, particularly bioavailability and degradation during digestion.
“Our rebrand is more than a new look — it reflects a shift in how we operate and engage across the nutraceutical sector,” said Anthony Armas, CEO of One Innovation Labs. “This phase represents a more direct presence in the market and a stronger emphasis on collaboration and scientific transparency.”
The announcement is timed ahead of Vitafoods Europe 2025, which will occur May 20–22 in Barcelona, Spain. The annual event brings together companies, researchers, and professionals from more than 100 countries to discuss ingredient innovation, regulatory developments, and formulation strategies within the global nutrition and health industries.
The company’s Founder and Chief Science Officer, Dr. Pedro Perez, Ph.D., will attend as a guest at Vitafoods Europe 2025, at Stand 3J70, to discuss the science underpinning the new delivery format and the broader development pipeline with industry stakeholders.
“Science has always guided our development process,” said Dr. Perez. “This new system reflects our continued focus on addressing known formulation limitations using methods that prioritize functional reliability and product viability.”
In addition to vitamin C, One Innovation Labs reports that its research and formulation work extends to additional ingredients and delivery systems. These projects are currently in development for use across various categories, each informed by ingredient timing, stability, absorption, and manufacturing scalability criteria.
About One Innovation Labs
One Innovation Labs is a formulation technology company specializing in delivery systems for bioactive ingredients. The company focuses on enhancing nutrient absorption, retention, and stability through platform-based solutions that support science-informed product development. One Innovation Labs collaborates with supplement and wellness brands globally.
Website: www.oneinnovationlabs.com
Media Contact:
Contact Person: Nadya Rousseau
Email: nadya@alternewmedia.com
Website: https://www.oneinnovationlabs.com
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Insure Information journalist was involved in the writing and production of this article.
